These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18725839)

  • 1. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
    Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
    Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States.
    Singal AG; Corley DA; Kamineni A; Garcia M; Zheng Y; Doria-Rose PV; Quinn VP; Jensen CD; Chubak J; Tiro J; Doubeni CA; Ghai NR; Skinner CS; Wernli K; Halm EA
    Am J Gastroenterol; 2018 May; 113(5):746-754. PubMed ID: 29487413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
    Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
    Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national survey of primary care physicians' methods for screening for fecal occult blood.
    Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
    Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving colorectal cancer screening in family medicine: an Oklahoma Physicians Resource/Research Network (OKPRN) study.
    Scheid DC; Hamm RM; Ramakrishnan K; McCarthy LH; Mold JW;
    J Am Board Fam Med; 2013; 26(5):498-507. PubMed ID: 24004701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of colorectal cancer screening in diverse primary care practices.
    Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
    BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?
    Carlson CM; Kirby KA; Casadei MA; Partin MR; Kistler CE; Walter LC
    Arch Intern Med; 2011 Feb; 171(3):249-56. PubMed ID: 20937917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.
    Klabunde CN; Lanier D; Nadel MR; McLeod C; Yuan G; Vernon SW
    Am J Prev Med; 2009 Jul; 37(1):8-16. PubMed ID: 19442479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.
    Myers RE; Turner B; Weinberg D; Hauck WW; Hyslop T; Brigham T; Rothermel T; Grana J; Schlackman N
    Prev Med; 2001 Oct; 33(4):249-60. PubMed ID: 11570828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.
    Gingold-Belfer R; Leibovitzh H; Boltin D; Issa N; Tsadok Perets T; Dickman R; Niv Y
    United European Gastroenterol J; 2019 Apr; 7(3):424-448. PubMed ID: 31019712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.
    Turner B; Myers RE; Hyslop T; Hauck WW; Weinberg D; Brigham T; Grana J; Rothermel T; Schlackman N
    J Gen Intern Med; 2003 May; 18(5):357-63. PubMed ID: 12795734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations.
    Nadel MR; Berkowitz Z; Klabunde CN; Smith RA; Coughlin SS; White MC
    J Gen Intern Med; 2010 Aug; 25(8):833-9. PubMed ID: 20383599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to full colon evaluation for a positive fecal occult blood test.
    Fisher DA; Jeffreys A; Coffman CJ; Fasanella K
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1232-5. PubMed ID: 16775188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.
    Myers RE; Hyslop T; Gerrity M; Schlackman N; Hanchak N; Grana J; Turner BJ; Weinberg D; Hauck WW
    Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):587-93. PubMed ID: 10428195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of complete diagnostic examination in clinical practice settings.
    Jimbo M; Meyer B; Hyslop T; Cocroft J; Turner BJ; Weinberg DS; Myers RE
    Cancer Detect Prev; 2006; 30(6):545-51. PubMed ID: 17113240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are physicians' recommendations for colorectal cancer screening guideline-consistent?
    Yabroff KR; Klabunde CN; Yuan G; McNeel TS; Brown ML; Casciotti D; Buckman DW; Taplin S
    J Gen Intern Med; 2011 Feb; 26(2):177-84. PubMed ID: 20949328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of colorectal cancer screening in a large medical organization.
    Hawley ST; Vernon SW; Levin B; Vallejo B
    Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):314-9. PubMed ID: 14973108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.